abemaciclib
eli lilly
['bcsm', 'abema', 'monarche,(-monarcher)', 'abemaciclib', 'monarche']
benefit of adjuvant abemaciclib in monarche was consistent among patients younger and older than 65yo. expectedly more frequent dose reductions and discontinuations among older patients. great presentation by . #asco23 #bcsm 
Medical Oncologist, Research Fellow @DanaFarber | @Harvard | PhD @LaStatale | former @IEOufficiale. Interested in breast oncology, HER2, ADCs & good music.